| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/19/2012 | US20120093816 Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus |
| 04/19/2012 | US20120093815 Fgf21 mutants and uses thereof |
| 04/19/2012 | US20120093814 Fusion Proteins Comprising Canine FC Portions |
| 04/19/2012 | US20120093813 Anti notch-1 antibodies |
| 04/19/2012 | US20120093812 Method of Treating Degenerative Disorders of the Nervous System |
| 04/19/2012 | US20120093811 Anti-vegf-d antibodies |
| 04/19/2012 | US20120093810 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 04/19/2012 | US20120093809 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms |
| 04/19/2012 | US20120093808 Humanized pcrv antibody having anti-pseudomonal activity |
| 04/19/2012 | US20120093807 Ror alpha promoting the induction of bmall |
| 04/19/2012 | US20120093806 Antitumor combinations containing antibodies recognizing specifically cd38 and cytarabine |
| 04/19/2012 | US20120093805 Anti-cd27 humanized monoclonal antibody |
| 04/19/2012 | US20120093804 Concatamers for Immunemodulation |
| 04/19/2012 | US20120093803 Means and methods of sterilization of biofunctional compositions |
| 04/19/2012 | US20120093802 Bioactive composition including stabilized protein and process for producing the same |
| 04/19/2012 | US20120093801 Targeted delivery of therapeutic agents with lyophilized matrices |
| 04/19/2012 | US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/19/2012 | US20120093777 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/19/2012 | US20120093770 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 04/19/2012 | US20120093769 Stem Cell Targeting with Dock-and-Lock (DNL) Complexes |
| 04/19/2012 | US20120093731 Gas-filled microvesicles with targeting ligand or therapeutic agent |
| 04/19/2012 | US20120093723 Nanocarrier compositions and methods |
| 04/19/2012 | US20120093719 Antibodies against prostate specific membrane antigen |
| 04/19/2012 | CA2817973A1 Antibodies that bind amyloid oligomers |
| 04/19/2012 | CA2814673A1 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay |
| 04/19/2012 | CA2814652A1 Human oncostatin m antibodies and methods of use |
| 04/19/2012 | CA2814643A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 04/19/2012 | CA2814431A1 Therapies for improving pulmonary function |
| 04/19/2012 | CA2814386A1 Antigen delivery platforms |
| 04/19/2012 | CA2814176A1 Methods and compositions for inducing a t-cell response to plasmodium species |
| 04/19/2012 | CA2814175A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine |
| 04/19/2012 | CA2813685A1 Recombinant modified vaccinia virus ankara influenza vaccine |
| 04/19/2012 | CA2813522A1 Novel antigen |
| 04/19/2012 | CA2813344A1 Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material |
| 04/19/2012 | CA2799442A1 Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
| 04/18/2012 | EP2441777A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 04/18/2012 | EP2441493A1 Methods for producing an immune response to tuberculosis |
| 04/18/2012 | EP2441472A1 Tumor therapy with an anti-VEGF antibody |
| 04/18/2012 | EP2441471A1 Reassortant influenza viruses |
| 04/18/2012 | EP2441470A1 Methods for producing an immune response to tuberculosis |
| 04/18/2012 | EP2441469A1 Methods for producing an immune response to tuberculosis |
| 04/18/2012 | EP2441468A2 Immunotherapy by using cell capable of co-expressing target antigen and cd1d and pulsed with cd1d ligand |
| 04/18/2012 | EP2441464A1 Specific therapy and medicament using integrin ligands for treating cancer |
| 04/18/2012 | EP2440921A1 Therapeutic agent and assay |
| 04/18/2012 | EP2440582A2 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 04/18/2012 | EP2440574A1 Stable immunogenic protein having multiple cysteines molecules process therefor and composition thereof |
| 04/18/2012 | EP2440246A2 Egfr and par2 regulation of intestinal permeability |
| 04/18/2012 | EP2440245A1 Benzonaphthyridine-containing vaccines |
| 04/18/2012 | EP2440244A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens |
| 04/18/2012 | EP2440243A1 Immunogenic compositions having low sodium chloride concentration |
| 04/18/2012 | EP2440242A1 Adjuvant compositions comprising a non-ionic isotonicity agent |
| 04/18/2012 | EP2440234A2 Immunological targeting of pathological tau proteins |
| 04/18/2012 | EP2440226A1 Vaccine therapy for choroidal neovascularization |
| 04/18/2012 | EP2200647B1 Antibodies specific for human hepcidin |
| 04/18/2012 | EP2200642B1 Meningococcal vaccine formulations |
| 04/18/2012 | EP2083855B1 Measles virus nucleoprotein for treating atherosclerosis |
| 04/18/2012 | EP2049155B1 Antitumor combinations containing taxane derivatives |
| 04/18/2012 | EP1910844B1 Cross-beta structure binding compounds |
| 04/18/2012 | EP1708745B1 Antibodies for oncogenic strains of hpv and methods of their use |
| 04/18/2012 | EP1534750B1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 04/18/2012 | EP1499358B1 Ph-sensitive polymer |
| 04/18/2012 | EP1390066B1 Vaccine composition |
| 04/18/2012 | EP1183368B1 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung |
| 04/18/2012 | EP0894143B2 Vmp-like sequences of pathogenic borrelia |
| 04/18/2012 | CN1738619B Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 04/18/2012 | CN102421802A 人源化的axl抗体 Humanized antibodies axl |
| 04/18/2012 | CN102421801A 抗-bcma抗体 Anti--bcma antibody |
| 04/18/2012 | CN102421449A 含14型肺炎球菌糖的组合 Portfolio containing 14 pneumococcal saccharide |
| 04/18/2012 | CN102421448A Modulators for her2 signaling in her2 expressing patients with gastric cancer |
| 04/18/2012 | CN102421444A 用于治疗瘘的自体和异体脂肪来源的基质干细胞组合物 For the treatment of autologous and allogeneic adipose-derived stromal stem cells fistula composition |
| 04/18/2012 | CN102421435A 使用PKC-θ抑制剂的免疫性疾病的离体治疗 In vitro treatment using inhibitors of PKC-θ autoimmune diseases |
| 04/18/2012 | CN102417537A Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| 04/18/2012 | CN102416177A 鸡新城疫-H<sub>9</sub>亚型禽流感二联双佐剂灭活疫苗及其制备方法 Newcastle -H <sub> 9 </ sub> and avian influenza subtype double adjuvant inactivated vaccine and its preparation method |
| 04/18/2012 | CN102416176A Stabile isotonic lyophilized protein formulation |
| 04/18/2012 | CN102416175A Medicament for treating HPV infection and application of medicament in preparation of medicament for treating HPV infection |
| 04/18/2012 | CN102416174A 猪o型口蹄疫重组噬菌体疫苗及其构建方法 Swine o-mouth disease vaccine and recombinant phage construction method |
| 04/18/2012 | CN102416173A 预防与猪环状病毒-2相关的心肌炎、流产和宫内感染 Prevention and porcine circovirus -2 associated myocarditis, abortion and intrauterine infection |
| 04/18/2012 | CN101914503B Canine distemper attenuated vaccine strain and application thereof |
| 04/18/2012 | CN101892175B Bovine capsular serotype A Pasteurella mutocida, validation identification and application thereof |
| 04/18/2012 | CN101875920B DcR3和GAD65双基因共表达重组腺病毒及其制备方法和应用 DcR3 and GAD65 gene co-expression of recombinant adenovirus double its preparation method and application |
| 04/18/2012 | CN101791401B 鱼用浸泡疫苗多组合佐剂及其应用和使用方法 Multi-soaked fish vaccine adjuvant and its application and use a combination of methods |
| 04/18/2012 | CN101757618B 一种嗜群血蜱的重组亚单位疫苗及其制备方法 One kind Haemaphysalis recombinant subunit vaccine and its preparation method |
| 04/18/2012 | CN101538574B 一种密码子优化的霍乱肠毒素ctb基因及其霍乱核酸疫苗 One kind of codon optimized cholera toxin and cholera ctb gene DNA vaccine |
| 04/18/2012 | CN101487016B 禽流感疫苗及其制备方法 Bird flu vaccine and its preparation method |
| 04/18/2012 | CN101299044B 一种多肽在制备自身免疫性肝炎诊断试剂上的应用 A polypeptide used in the preparation of a diagnostic agent of autoimmune hepatitis |
| 04/18/2012 | CN101104641B 作为猪生殖和呼吸道征候群疫苗的prrs病毒的融合蛋白 As porcine reproductive and respiratory syndrome virus vaccine prrs fusion proteins |
| 04/18/2012 | CN101043904B Nutritional composition comprising indigestible oligosaccharides |
| 04/18/2012 | CN101043902B Vaccine composition against hepatitis c virus |
| 04/17/2012 | US8158855 Immunization of fish with plant-expressed recombinant proteins |
| 04/17/2012 | US8158760 Glycoengineered, recombinant antibody |
| 04/17/2012 | US8158751 Peptides for detection of antibody to Ehrlichia ewingii |
| 04/17/2012 | US8158602 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 04/17/2012 | US8158594 CYP1B1 nucleic acids and methods of use |
| 04/17/2012 | US8158592 for treatment of atopic conditions (dermatitis, allergies); point mutations; immunotherapy |
| 04/17/2012 | US8158585 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders |
| 04/17/2012 | US8158582 Methods for treatment of insulin-like growth factor-1 deficiency |
| 04/17/2012 | US8158416 CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins |
| 04/17/2012 | US8158371 Assay for antibodies to Mycobacterium paratuberculosis |
| 04/17/2012 | US8158341 Efficient algorithm for PCR testing of blood samples |
| 04/17/2012 | US8158133 Pharmaceutical composition useful for vaccines |